MENINGIOMA
Clinical trials for MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA trials appear
Sign up with your email to follow new studies for MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Trial tests Gadolinium-Free MRI dye to spot brain tumors and MS lesions
Diagnosis CompletedThis study tested a new type of MRI contrast dye called RVP-001, which is based on manganese instead of the commonly used gadolinium. It involved 18 adults with known brain or spinal cord lesions from conditions like tumors or multiple sclerosis. The main goal was to see if RVP-0…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Apr 03, 2026 22:55 UTC
-
Brain scan breakthrough: same accuracy with 84% less dye?
Diagnosis CompletedThis study tested whether a special type of MRI scan could detect a common brain tumor called a meningioma using a much smaller dose of contrast dye. Researchers compared new scanning techniques using only one-sixth of the standard dye dose against the current best method in 514 …
Matched conditions: MENINGIOMA
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
Sleep help for brain tumor patients: new therapy trial
Symptom relief CompletedThis study tested whether a talk therapy program for insomnia (CBT-I) is practical and helpful for people with primary brain tumors who have trouble sleeping. Researchers worked with 70 participants to see if they could successfully recruit people, deliver the therapy online, and…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Feb 25, 2026 15:07 UTC
-
Scientists test DNA blueprint method to find better treatments for kids with tough cancers
Knowledge-focused CompletedThis study tested whether doctors could quickly analyze the genetic makeup of a child's tumor and use that information to choose a personalized treatment plan. It involved 186 children and young adults (up to age 21) whose cancers had returned or did not respond to standard treat…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: Giselle Sholler • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC